| Phytochemical Name | Glucosinalbate |
| PubChem CID | 145925702 |
| Disease Indication | Ehrlich ascites carcinoma [ICD-11: 2D91] Investigative |
| Interaction Partner | Anticancer drug Name: Doxorubicin |
| Source |
Even
Arabidopsis thaliana
|
| Phytochemical Name | Niacinamide |
| PubChem CID | 936 |
| Disease Indication | Primary Open Angle Glaucoma [ICD-11: 9C61.0Z] Phase 3 |
| Interaction Partner | Anticancer drug Name: Albiglutide; Alogliptin; Canagliflozin; Chlorpropamide; Dapagliflozin; Dulaglutide; Empagliflozin; Ertugliflozin; Exenatide; Gemcitabine; Glimepiride; Glipizide; Glucobay; Glyburide; Insulin aspart (aspart); Insulin degludec; Insulin detemir; Insulin glargine; Insulin glulisine; Insulin human (isophane); Insulin human (regular); Insulin human (zinc extended); Insulin human (zinc); Insulin lispro; Linagliptin; Liraglutide; Lixisenatide; Metformin; Miglitol; Nateglinide; Pioglitazone; Pramlintide; Repaglinide; Rosiglitazone; Saxagliptin; Semaglutide; Sitagliptin; Tolazamide; Tolbutamide |
| Source |
Unknown
Arabidopsis thaliana
|
| Phytochemical Name | Nicotinic acid |
| PubChem CID | 938 |
| Disease Indication | Glioblastoma multiforme [ICD-11: 2A00] Phase 2 |
| Interaction Partner | Anticancer drug Name: Copper (I) |
| Source |
Unknown
Arabidopsis thaliana
|
| Phytochemical Name | Glucosinalbate |
| PubChem CID | 145925702 |
| Disease Indication | Ehrlich ascites carcinoma [ICD-11: 2D91] Investigative |
| Interaction Partner | Anticancer drug Name: Doxorubicin |
| Source |
Even
Arabidopsis thaliana
|
| Phytochemical Name | Niacinamide |
| PubChem CID | 936 |
| Disease Indication | Primary Open Angle Glaucoma [ICD-11: 9C61.0Z] Phase 3 |
| Interaction Partner | Anticancer drug Name: Albiglutide; Alogliptin; Canagliflozin; Chlorpropamide; Dapagliflozin; Dulaglutide; Empagliflozin; Ertugliflozin; Exenatide; Gemcitabine; Glimepiride; Glipizide; Glucobay; Glyburide; Insulin aspart (aspart); Insulin degludec; Insulin detemir; Insulin glargine; Insulin glulisine; Insulin human (isophane); Insulin human (regular); Insulin human (zinc extended); Insulin human (zinc); Insulin lispro; Linagliptin; Liraglutide; Lixisenatide; Metformin; Miglitol; Nateglinide; Pioglitazone; Pramlintide; Repaglinide; Rosiglitazone; Saxagliptin; Semaglutide; Sitagliptin; Tolazamide; Tolbutamide |
| Source |
Unknown
Arabidopsis thaliana
|
| Phytochemical Name | Nicotinic acid |
| PubChem CID | 938 |
| Disease Indication | Glioblastoma multiforme [ICD-11: 2A00] Phase 2 |
| Interaction Partner | Anticancer drug Name: Copper (I) |
| Source |
Unknown
Arabidopsis thaliana
|
| Phytochemical Name | Glucosinalbate |
| PubChem CID | 145925702 |
| Disease Indication | Ehrlich ascites carcinoma [ICD-11: 2D91] Investigative |
| Interaction Partner | Anticancer drug Name: Doxorubicin |
| Source |
Even
Arabidopsis thaliana
|
| Phytochemical Name | Niacinamide |
| PubChem CID | 936 |
| Disease Indication | Primary Open Angle Glaucoma [ICD-11: 9C61.0Z] Phase 3 |
| Interaction Partner | Anticancer drug Name: Albiglutide; Alogliptin; Canagliflozin; Chlorpropamide; Dapagliflozin; Dulaglutide; Empagliflozin; Ertugliflozin; Exenatide; Gemcitabine; Glimepiride; Glipizide; Glucobay; Glyburide; Insulin aspart (aspart); Insulin degludec; Insulin detemir; Insulin glargine; Insulin glulisine; Insulin human (isophane); Insulin human (regular); Insulin human (zinc extended); Insulin human (zinc); Insulin lispro; Linagliptin; Liraglutide; Lixisenatide; Metformin; Miglitol; Nateglinide; Pioglitazone; Pramlintide; Repaglinide; Rosiglitazone; Saxagliptin; Semaglutide; Sitagliptin; Tolazamide; Tolbutamide |
| Source |
Unknown
Arabidopsis thaliana
|
| Phytochemical Name | Nicotinic acid |
| PubChem CID | 938 |
| Disease Indication | Glioblastoma multiforme [ICD-11: 2A00] Phase 2 |
| Interaction Partner | Anticancer drug Name: Copper (I) |
| Source |
Unknown
Arabidopsis thaliana
|
